MedGenome
Leading provider of genomic solutions in South Asia, specializing in advanced genetic testing, clinical diagnostics, and bioinformatics solutions for personalized healthcare and genomic research.
Notes
MedGenome is one of the largest genomics companies in South Asia, providing comprehensive genetic testing and research services. The company offers a wide range of genomic tests for clinical diagnostics, including whole genome sequencing, whole exome sequencing, and targeted panels for various diseases.
With operations in India, the US, and expansion into Africa and the Middle East, MedGenome serves both clinical laboratories seeking diagnostic solutions and pharmaceutical companies requiring genomic research services. The company has built one of the largest South Asian genomic databases, providing unique insights into genetic variants prevalent in these populations.
Team
- Sam Santhosh - Founder & Chairman
- LinkedIn: linkedin.com/in/samsanthosh
- Sumanth Chandrashekara, M.D. - Chief Medical Officer
Additional Research Findings
- Founded in 2013
- Dual headquarters in Bangalore, India and Foster City, California
- Raised $50 million in August 2022, led by Novo Holdings
- One of the largest South Asian genomic databases
- Expanding into Africa and Middle East markets
- Clinical diagnostics and research services
- Personalized medicine applications
- CAP and NABL accredited laboratories
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Novo Holdings | Hellerup, Denmark | biotech-focused | seedseries-a+3 | 13 |